$17.47 0.05 (+0.29%)
11/6/2009 4:00 PM

Mylan Laboratories, Inc. (MYL)

CAPS Rating: 3 out of 5

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.

Current Price $17.47 Mkt Cap $5.34B
Open $17.28 P/E Ratio 108.88
Prev. Close $17.42 Div. (Yield) 0.24 (1.20%)
Daily Range $17.11 - $17.49 Volume 4,514,423
52-Wk Range $7.09 - $17.44 Avg. Daily Vol. 8,099,000

MYL News and Commentary

View All MYL News and Commentary

Caps

How do you think MYL will perform vs the S&P 500?

Add Stock to Watchlist

All Members

502 Outperform
35 Underperform
 

All-Star Members

151 Outperform
6 Underperform
 

Wall Street

15 Outperform
1 Underperform
 

Top MYL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

RXDOC73 (99.28)
Submitted October 28, 2008

The population is just getting older and more people are going to need more drugs. There is a great deal of consolidation in the field and only the strong companies like this one will survive the fallout.

Also a great takeover target for… More

1 Comment | Reply | Report this Post

DouglasRich (< 20)
Submitted January 29, 2008

Mylan is known for making good quality, reliable generic pharmaceutical products, but I think their primary drawback is they haven't found a way to outcompete the generic market. In the pharmacy, cheaper generics are preferred to Mylan's oftentimes… More

1 Comment | Reply | Report this Post
MYL VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about MYL.

Recs

0
Member Avatar bobsweet (36.79) Submitted: 9/28/2009 9:17:38 AM : Outperform Start Price: $16.15 MYL Score: +6.00

Love the company. Generic medicine will boost with Obamas healtcare plan. Not to mention new FDA approvals, including HIV pill approval. I am just waiting for this comapny to explode!!!!

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar dutchredneck (38.84) Submitted: 9/23/2009 10:30:55 AM : Outperform Start Price: $16.11 MYL Score: +8.38

Growth stock will outperform the S&P.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar 8tune (59.73) Submitted: 9/9/2009 1:46:27 PM : Outperform Start Price: $14.27 MYL Score: +18.75

Mylan generic pharma to outperform S&P.

Report this Post 0 Comments | Reply | Permalink
View All 91 Pitches »

Leaderboard

Find the members with the highest scoring picks in MYL.

Score Leader

Allakazam

Allakazam (99.14) Score: +157.45

The Score Leader is the member with the highest score across all their picks in MYL.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
Allakazam 99.14 10/27/2008 Outperform NS $6.14 +184.53% +27.07% +157.45
DustinCody 99.17 10/24/2008 Outperform NS $6.25 +179.52% +27.22% +152.30
csbdorado 93.50 10/23/2008 Outperform NS $7.07 +147.10% +21.48% +125.62
RyanIdaho 92.47 10/9/2008 Outperform NS $7.66 +128.07% +16.94% +111.12
jmoney14 < 20 10/6/2008 Outperform 1Y $8.01 +118.10% +8.64% +109.46
bernleeds 33.09 10/21/2008 Outperform 1Y $7.81 +123.69% +14.26% +109.43
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. biotech4ever 79.18 10/30/2008 Outperform 5Y $8.00 +118.38% +16.09% +102.29 1 Comment
Piner75 59.84 10/20/2008 8/3/2009 Outperform 1Y $8.20 +113.05% +13.92% +99.13
StopTrading 99.54 10/7/2008 Outperform NS $9.02 +93.68% +2.90% +90.78
HahaCAPS 93.40 10/6/2008 Outperform NS $8.95 +95.20% +5.94% +89.26
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackRBCCapMkts 81.74 4/23/2009 Outperform NS $14.49 +20.57% +27.80% -7.23
TrackBarclaysCap 86.02 2/23/2009 Outperform NS $12.99 +34.49% +39.30% -4.81
TrackStanfordRes 80.42 9/25/2008 Outperform NS $12.02 +45.34% -8.03% +53.37
TrackNeedham < 20 9/25/2008 Outperform NS $12.02 +45.34% -8.03% +53.37
TrackCarisandCo 78.62 6/13/2008 Outperform NS $12.56 +14.25% -23.31% +37.56 9/9/2009 @ $14.35
TrackScottBleier 63.76 6/13/2008 Outperform 3M $12.59 +38.76% -18.40% +57.16
TrackBerkowitz 76.75 5/27/2008 Outperform 1Y $12.58 -36.57% -40.23% +3.67 11/24/2008 @ $7.98 2 Comments
TrackSoros 65.62 3/31/2008 Outperform NS $11.60 +50.60% -15.82% +66.42 1 Comment
TrackCitigroup 21.22 3/14/2008 Outperform NS $11.17 +56.40% -15.91% +72.31
TrackPatDorsey 80.29 1/4/2008 Outperform 5Y $13.69 +27.61% -20.99% +48.60
TrackBofASec 93.50 12/18/2007 Outperform NS $13.80 +26.59% -23.18% +49.77
TrackBernstein 86.97 11/15/2007 Outperform NS $14.27 +22.42% -23.42% +45.84
TrackJPMorgan 78.71 10/4/2007 Outperform NS $17.21 +1.51% -27.17% +28.68
TrackDreman 89.07 9/30/2007 Outperform NS $15.96 +9.46% -26.44% +35.90 2 Comments
TrackCreditSuiss 91.16 9/10/2007 Outperform NS $15.59 +12.06% -23.04% +35.09
TrackUBS 86.41 9/10/2007 Outperform NS $15.59 +12.06% -23.04% +35.09
TrackMatrix 89.45 11/20/2006 Outperform NS $20.67 -15.49% -18.92% +3.43
TrackBofASec 93.50 8/25/2006 Underperform NS $20.50 -32.70% +12.57% +45.27 12/18/2007 @ $13.80
TrackJimCramer < 20 8/9/2006 Underperform 3W $19.75 -11.54% -10.53% +1.00

Featured Broker Partners